UniProt ID | DYRK2_HUMAN | |
---|---|---|
UniProt AC | Q92630 | |
Protein Name | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | |
Gene Name | DYRK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 601 | |
Subcellular Localization | Cytoplasm. Nucleus. Translocates into the nucleus following DNA damage. | |
Protein Description | Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro).. | |
Protein Sequence | MLTRKPSAAAPAAYPTGRGGDSAVRQLQASPGLGAGATRSGVGTGPPSPIALPPLRASNAAAAAHTIGGSKHTMNDHLHVGSHAHGQIQVQQLFEDNSNKRTVLTTQPNGLTTVGKTGLPVVPERQLDSIHRRQGSSTSLKSMEGMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKRITESTGAITSISKLPPPSSSASKLRTNLAQMTDANGNIQQRTVLPKLVS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MLTRKPSAAAPAAY -CCCCCCCCCCCCCC | 33.31 | 28348404 | |
14 | Phosphorylation | SAAAPAAYPTGRGGD CCCCCCCCCCCCCCH | 11.93 | 23312004 | |
16 | Phosphorylation | AAPAAYPTGRGGDSA CCCCCCCCCCCCHHH | 27.17 | 23312004 | |
18 | Methylation | PAAYPTGRGGDSAVR CCCCCCCCCCHHHHH | 48.69 | - | |
30 | Phosphorylation | AVRQLQASPGLGAGA HHHHHHCCCCCCCCC | 13.41 | 30266825 | |
40 | Phosphorylation | LGAGATRSGVGTGPP CCCCCCCCCCCCCCC | 33.21 | 30266825 | |
44 | Phosphorylation | ATRSGVGTGPPSPIA CCCCCCCCCCCCCCC | 44.07 | 30266825 | |
48 | Phosphorylation | GVGTGPPSPIALPPL CCCCCCCCCCCCCCC | 31.88 | 30266825 | |
98 | Phosphorylation | QQLFEDNSNKRTVLT EHHHCCCCCCCEEEE | 56.93 | 22468782 | |
106 | Phosphorylation | NKRTVLTTQPNGLTT CCCEEEEECCCCCEE | 37.56 | 22817900 | |
136 | Phosphorylation | SIHRRQGSSTSLKSM HHHHCCCCCCCCHHH | 23.31 | 29978859 | |
137 | Phosphorylation | IHRRQGSSTSLKSME HHHCCCCCCCCHHHC | 28.92 | 29978859 | |
138 | Phosphorylation | HRRQGSSTSLKSMEG HHCCCCCCCCHHHCC | 39.51 | 29978859 | |
139 | Phosphorylation | RRQGSSTSLKSMEGM HCCCCCCCCHHHCCC | 35.43 | 29978859 | |
142 | Phosphorylation | GSSTSLKSMEGMGKV CCCCCCHHHCCCCCC | 27.62 | 29978859 | |
292 | Phosphorylation | IHMLENFTFRNHICM HHHHHHCCCCCCHHH | 33.01 | 25690035 | |
309 | Phosphorylation | ELLSMNLYELIKKNK HHHHCCHHHHHHHCC | 12.04 | 19664995 | |
331 | Phosphorylation | LVRKFAHSILQCLDA HHHHHHHHHHHHHHH | 22.89 | 29116813 | |
347 | S-nitrosylation | HKNRIIHCDLKPENI HHCCEEECCCCHHHE | 4.64 | 24105792 | |
373 | S-nitrosylation | VIDFGSSCYEHQRVY EEECCCCHHCHHHHH | 5.04 | 24105792 | |
380 | Phosphorylation | CYEHQRVYTYIQSRF HHCHHHHHHHHHHHH | 8.94 | 24260401 | |
381 | Phosphorylation | YEHQRVYTYIQSRFY HCHHHHHHHHHHHHC | 15.99 | 27794612 | |
382 | Phosphorylation | EHQRVYTYIQSRFYR CHHHHHHHHHHHHCC | 4.54 | 19664994 | |
385 | Phosphorylation | RVYTYIQSRFYRAPE HHHHHHHHHHCCCCH | 18.13 | 22617229 | |
442 | Phosphorylation | IELLGMPSQKLLDAS HHHHCCCCHHHHHHH | 30.93 | 22817900 | |
449 | Phosphorylation | SQKLLDASKRAKNFV CHHHHHHHHHHHHHH | 23.49 | 23362280 | |
464 | Phosphorylation | SSKGYPRYCTVTTLS HCCCCCCEEEEEECC | 6.48 | 19664995 | |
466 | Phosphorylation | KGYPRYCTVTTLSDG CCCCCEEEEEECCCC | 16.38 | 29083192 | |
468 | Phosphorylation | YPRYCTVTTLSDGSV CCCEEEEEECCCCCE | 12.13 | 29083192 | |
469 | Phosphorylation | PRYCTVTTLSDGSVV CCEEEEEECCCCCEE | 21.67 | 29083192 | |
471 | Phosphorylation | YCTVTTLSDGSVVLN EEEEEECCCCCEEEC | 37.52 | 29083192 | |
474 | Phosphorylation | VTTLSDGSVVLNGGR EEECCCCCEEECCCC | 17.65 | 29083192 | |
525 | Phosphorylation | WDPAVRMTPGQALRH CCCCCCCCCCCHHCC | 17.44 | 19413330 | |
544 | Phosphorylation | RRLPKPPTGEKTSVK HCCCCCCCCCCCCEE | 67.51 | 28348404 | |
554 | Phosphorylation | KTSVKRITESTGAIT CCCEEEEHHCCCCEE | 28.10 | 28270605 | |
556 | Phosphorylation | SVKRITESTGAITSI CEEEEHHCCCCEEEH | 24.40 | 28270605 | |
557 | Phosphorylation | VKRITESTGAITSIS EEEEHHCCCCEEEHH | 25.13 | 28270605 | |
561 | Phosphorylation | TESTGAITSISKLPP HHCCCCEEEHHHCCC | 21.34 | 28270605 | |
562 | Phosphorylation | ESTGAITSISKLPPP HCCCCEEEHHHCCCC | 20.82 | 28270605 | |
564 | Phosphorylation | TGAITSISKLPPPSS CCCEEEHHHCCCCCC | 28.10 | 28270605 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
106 | T | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
381 | T | Phosphorylation | Kinase | MLK2 | Q02779 | PSP |
442 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
449 | S | Phosphorylation | Kinase | MLK2 | Q02779 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:19965871 |
- | K | Ubiquitination | E3 ubiquitin ligase | SIAH2 | O43255 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DYRK2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in theapoptotic response to DNA damage."; Taira N., Yamamoto H., Yamaguchi T., Miki Y., Yoshida K.; J. Biol. Chem. 285:4909-4919(2010). Cited for: SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-106 AND SER-442 BY ATM,UBIQUITINATION BY MDM2, INTERACTION WITH MDM2, MUTAGENESIS OF THR-106;SER-442 AND 189-LYS--ARG-191, NUCLEAR LOCALIZATION SIGNAL, ANDINDUCTION BY DNA DAMAGE. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-382, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-382, AND MASSSPECTROMETRY. |